FDA Approved Medical Products for:

Mantle cell lymphoma

The table(s) below may not be an exhaustive list of drugs or products used to treat this condition. There may be other products available that are not considered orphan products.

Generic Name ibrutinib
Trade Name
(Manufacturer Name)
Imbruvica
(Pharmacyclics, Inc.)
Indication
The FDA has approved this product to be used in this manner.
Treatment of patients with mantle cell lymphoma (MCL) who have received at least one prior therapy. Treatment of patients with chronic lymphocytic leukemia (CLL) who have received at least one prior therapy.
More Information about this product Drug Information Portal

Generic Name Lenolidomide
Trade Name
(Manufacturer Name)
Revlimid
Indication
The FDA has approved this product to be used in this manner.
Treatment of mantle cell lymphoma whose disease has relapsed or progressed after two prior therapies, one of which included bortezomib.
More Information about this product Drug Information Portal